References
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Yin A, Li B, Luo M, et al. The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China. PLOS One. 2014;9(2):e89855.
- Piel FB, Weatherall DJ. The α-thalassemias. N Engl J Med. 2014;371(20):1908–1916.
- Chui DH. α-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann NY Acad Sci. 2005;1054:25–32.
- Fleming PJ, Hughes WG, Farmilo RK, et al. Hemoglobin Westmead α2122(H5)His–>Glnβ2: a new hemoglobin variant with the substitution in the α1 and β1 contact area. Hemoglobin. 1980;4(1):39–52.
- Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
- Yang Y, Lou JW, Liu YH, et al. Screening and diagnosis of Hb Quong Sze [HBA2: c.377T>C (or HBA1)] in a prenatal control program for thalassemia. Hemoglobin. 2014;38(3):158–160.
- Jiang F, Xu LL, Chen GL, et al. Hematological characteristics of Hb Constant Spring (HBA2: c.427T>C) carriers in Mainland China. Hemoglobin. 2020;:1–3. Apr 27; Online ahead of print.
- Zhao J, Li J, Lai Q, et al. Combined use of gap-PCR and next-generation sequencing improves thalassaemia carrier screening among premarital adults in China. J Clin Pathol. 2020; Jan 24; jclinpath-2019-206339. Online ahead of print.
- He J, Song W, Yang J, et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017;19(9):1022–1031.
- Zhang H, Li C, Li J, et al. Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou Region, P.R. China. J Clin Lab Anal. 2019;33(4):e22845.
- Skogerboe KJ, West SF, Smith C, et al. Screening for α-thalassemia. Correlation of Hemoglobin H inclusion bodies with DNA-determined genotype. Arch Pathol Lab Med. 1992;116(10):1012–1018.